Skip to main content
Fig. 3 | Clinical Proteomics

Fig. 3

From: Prediction of neoadjuvant chemotherapeutic efficacy in patients with locally advanced gastric cancer by serum IgG glycomics profiling

Fig. 3

ROC curve analyses for the prediction of NACT efficacy in patients with gastric cancer. Three models were constructed to predict the NACT efficacy. The blue line represents “Clinical-model” that consisted with age, histology and regimen. The yellow line represents “Glyco-model” consisted with GP4(H3N4F1), GP6(H3N5F1), and GP18(H5N4F1S1). The red line represents “Combined-model” that combined two models variate mentioned above

Back to article page

Clinical Proteomics

ISSN: 1559-0275